Masayuki Amagai
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 278 publications
Not a new society, but a new way to connect: ISID-APAC as a new model for collaboration in investigative dermatology.
Journal: The Journal of investigative dermatology
Published: April 26, 2026
Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).
Journal: BMC cancer
Published: January 27, 2026
Mechanistic insights into emerging therapeutic platforms: The 72nd annual Montagna Symposium on the Biology of Skin.
Journal: The Journal of investigative dermatology
Published: January 15, 2026
Regulatory T cells: From Foxp3 to tolerance-inducing therapies.
Journal: The Journal of investigative dermatology
Published: January 09, 2026
Correction: Generation of Human Melanocytes from Induced Pluripotent Stem Cells.
Journal: PloS one
Published: November 24, 2025
A Case of Annular Pustular Psoriasis Possibly Triggered by Cabozantinib and Edoxaban During Nivolumab Therapy.
Journal: The Journal of dermatology
Published: November 02, 2025
Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris.
Journal: Science translational medicine
Published: October 22, 2025
Keratinocyte-neutrophil interactions revealed as targetable drivers of sustained inflammation in Sweet syndrome.
Journal: The Journal of clinical investigation
Published: October 15, 2025
Microbial dysbiosis and foot odor in Nagashima-type palmoplantar keratosis: Improvement with topical benzoyl peroxide.
Journal: The Journal of investigative dermatology
Published: August 06, 2025
Clinical progress of engineered cellular immunotherapies for autoimmunity.
Journal: Nature biotechnology
Published: July 25, 2025
Last Updated: 09/26/2026